Chinese Herbal Medicine for Hyperlipidaemia: A Review Based on Data Mining from 1990 to 2016

医学 梅德林 科克伦图书馆 观察研究 随机对照试验 中医药 传统医学 替代医学 内科学 病理 政治学 法学
作者
Liang Dai,Aiping Lü,Linda L. D. Zhong,Guang Zheng,Zhaoxiang Bian
出处
期刊:Current Vascular Pharmacology [Bentham Science Publishers]
卷期号:15 (6) 被引量:16
标识
DOI:10.2174/1570161115666170713163127
摘要

Background: Many studies have shown that the reduction of low density lipoprotein (LDLC) levels provides cardiovascular protection; therefore LDL-C is considered to be a core therapeutic target in anti-hyperlipidaemia treatment. However, the LDL-C goal attainment is often not satisfied in China with conventional lipid-lowering agents. Many patients seek help from Chinese Herbal Medicine (CHM). To further understand the current use of CHM in hyperlipidaemia, we conducted a review based on a systematic literature search and data mining. Methods: We comprehensively searched MEDLINE, EBSCO, Cochrane Library, EMBASE, Chinese Biomedical Literature Database (CBM), Chinese Scientific Journal Database (VIP), China National Knowledge Infrastructure (CNKI) and Wanfang database to identify potentially relevant articles. We included literatures that met the following criteria: (1) randomized or non-randomized controlled trials; (2) observational clinical trials; (3) case series or case reports. In order to enrich the systematic literature searching and provide the quantitative relationship between relative items and the treatment of hyperlipidaemia, the data mining was also conducted by filtering the biomedical literature on hyperlipidaemia in SinoMed and other available databases like VIP and CNKI. Results: In summary, 282 records of CHM on hyperlipidaemia were captured and analysed. The top used single herb was Radix Salviae Miltiorrhizae. The most frequently used formula was Xuefuzhuyu Decoction. The most used herbs in clinical practice have some pharmacological evidences. The mechanisms are different, but could be classified into three categories: inhibiting synthesis, increasing decomposition and reducing absorption. Conclusion: CHM shows positive effect in the treatment of hyperlipidaemia and has the potential to be used in combination with conventional drugs. However, their use should be demonstrated in highquality clinical trials and clinicians should pay attention to potential herb-drug interactions. Keywords: Hyperlipidaemia, chinese herbal medicine, traditional chinese medicine, pharmacological mechanism, data mining, CNKI.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Loooong应助zzww采纳,获得10
刚刚
忐忑的方盒完成签到,获得积分10
刚刚
于大强完成签到,获得积分10
1秒前
李爱国应助liu采纳,获得10
1秒前
星星完成签到,获得积分10
1秒前
嘻嘻完成签到,获得积分10
1秒前
Joyi发布了新的文献求助30
2秒前
甜甜的寻真完成签到,获得积分10
2秒前
小梁完成签到,获得积分10
2秒前
victorzou完成签到,获得积分10
2秒前
大个应助王娟采纳,获得10
2秒前
Owen应助大侠刘川枫采纳,获得10
2秒前
3秒前
青珊发布了新的文献求助50
3秒前
3秒前
FashionBoy应助萧东辰采纳,获得10
3秒前
王大京发布了新的文献求助10
3秒前
3秒前
heqingqing发布了新的文献求助10
3秒前
科研通AI5应助整齐千柳采纳,获得10
4秒前
4秒前
为科研奋斗完成签到,获得积分10
4秒前
4秒前
willow完成签到,获得积分20
4秒前
木头人呐完成签到 ,获得积分10
5秒前
silent完成签到,获得积分10
5秒前
5秒前
liu完成签到,获得积分10
5秒前
听风轻语发布了新的文献求助10
5秒前
6秒前
华仔应助Ace采纳,获得10
6秒前
Jasper应助lmh采纳,获得10
6秒前
qinz完成签到,获得积分10
6秒前
单纯炎彬发布了新的文献求助20
7秒前
qdr发布了新的文献求助30
7秒前
田様应助azysf采纳,获得10
7秒前
FashionBoy应助张大旺采纳,获得10
9秒前
万能图书馆应助孙昕悦采纳,获得10
9秒前
9秒前
9秒前
高分求助中
Comprehensive Toxicology Fourth Edition 24000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Hydrothermal Circulation and Seawater Chemistry: Links and Feedbacks 1200
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
Risankizumab Versus Ustekinumab For Patients with Moderate to Severe Crohn's Disease: Results from the Phase 3B SEQUENCE Study 600
Oxford Learner's Pocket Word Skills 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5151452
求助须知:如何正确求助?哪些是违规求助? 4347121
关于积分的说明 13535816
捐赠科研通 4189850
什么是DOI,文献DOI怎么找? 2297713
邀请新用户注册赠送积分活动 1298040
关于科研通互助平台的介绍 1242709